Table I.
Clinical characteristic of the patients
| Age | Sex | Reynoud ph | Sclerosis | TSS | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Min. | Max. | Mean | F | M | lSSc | dSSc | Min. | Max. | Mean | Min. | Max. | Mean | Min. | Max. | Mean | ||
| SSc | ANG | 38 | 77 | 54 | 45 | 5 | 41 | 9 | 1 | 30 | 9 | 1 | 20 | 7 | 4 | 40 | 15 |
| SDF-1α | 20 | 70 | 52 | 24 | 1 | 18 | 7 | 1 | 30 | 9 | 1 | 15 | 6 | 4 | 32 | 15 | |
| Control | ANG | 34 | 68 | 50 | 21 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SDF-1α | 21 | 68 | 49 | 16 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
SSc – systemic sclerosis group, Control – control group, Reynould ph – Reynoud phenomenon duration, Sclerosis – sclerosis duration, TSS – Total Skin Score, F – female, M – male, lSSc – limited SSc, dSSc – diffuse SSc